most citedApplications of artificial intelligence in drug development using real-world data

101 citations · 153 across the 6 of their papers we have counts for

collaborators

8 papers

cs.CL202113 cited

Clinical Relation Extraction Using Transformer-based Models

Xi Yang, Zehao Yu, Yi Guo +2

The newly emerged transformer technology has a tremendous impact on NLP research. In the general English domain, transformer-based models have achieved state-of-the-art performance…

cs.LG2021

Explaining Algorithmic Fairness Through Fairness-Aware Causal Path Decomposition

Weishen Pan, Sen Cui, Jiang Bian +2

Algorithmic fairness has aroused considerable interests in data mining and machine learning communities recently. So far the existing research has been mostly focusing on the devel…

cs.CL202138 cited

A Study of Social and Behavioral Determinants of Health in Lung Cancer Patients Using Transformers-based Natural Language Processing Models

Zehao Yu, Xi Yang, Chong Dang +8

Social and behavioral determinants of health (SBDoH) have important roles in shaping people's health. In clinical research studies, especially comparative effectiveness studies, fa…

q-bio.GN2021

Assessing putative bias in prediction of anti-microbial resistance from real-world genotyping data under explicit causal assumptions

Mattia Prosperi, Simone Marini, Christina Boucher +1

Whole genome sequencing (WGS) is quickly becoming the customary means for identification of antimicrobial resistance (AMR) due to its ability to obtain high resolution information…

cs.CL20211 cited

Deep Learning Models in Detection of Dietary Supplement Adverse Event Signals from Twitter

Yefeng Wang, Yunpeng Zhao, Jiang Bian +1

Objective: The objective of this study is to develop a deep learning pipeline to detect signals on dietary supplement-related adverse events (DS AEs) from Twitter. Material and Met…

cs.CL2021

A Conversational Agent System for Dietary Supplements Use

Esha Singh, Anu Bompelli, Ruyuan Wan +3

Dietary supplements (DS) have been widely used by consumers, but the information around the efficacy and safety of DS is disparate or incomplete, thus creating barriers for consume…